WILMINGTON, DE — Womble Bond Dickinson attorney Mary W. Bourke will lead a discussion of a significant Zoom patent trial at the Consero IP Virtual Forum for Life Sciences on December 7–8, 2020.  

Bourke’s presentation, entitled “Lessons Learned from The First ZOOM Trial in the SDNY – A Case Study” will chronicle a case in which Womble Bond Dickinson earned a major patent victory for client Ferring Pharmaceuticals, Inc. in the first Zoom trial in the Southern District of New York during the pandemic. The 8-day trial in July 2020 was fully remote, with witnesses and counsel appearing via Zoom. The firm was recognized as a “Legal Lion” by Law360 for its significant win in this case. 

Other Womble Bond Dickinson attorneys participating in the Forum include intellectual property partners Cristin H. Cowles, Ph.D., Joshua P. Davis and Danielle L. Herritt. The firm is a sponsor of the Consero event. 

Consero Group is an international leader in creating high-level invitation-only events for senior executives. Since its inception in 2010, the company has hosted over 200 events in the U.S. and Europe across a variety of industries. 

Mary Bourke leads Womble Bond Dickinson’s Life Sciences and Pharmaceuticals Sector and has more than 30 years of experience representing various clients in patent litigation at both the district court and appellate levels. Mary has been lead or co-lead litigation counsel for various pharmaceutical companies and has litigated patents that cover new chemical entities, polymorphs, formulations, methods of treatment, dosing regimes, and other pharmaceutical and life sciences patents. She has been lead counsel on multiple ANDA and biologics cases and understands the importance of coordinating ANDA litigation with parallel FDA actions. Mary also has been lead and/or oversight counsel for various clients in post-grant proceedings, including inter partes reviews.